Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral trimetazidine for acute mountain sickness symptoms and exercise performance
ChiCTR-TRC-13003298Phase 4Completed
- Sponsor
- Institute of Cardiovascular Diseases, Xinqiao Hospital
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of trimetazidine in acute mountain sickness (AMS) (2 arms), sponsored by Institute of Cardiovascular Diseases, Xinqiao Hospital. Primary endpoints: PWC170, blood lactic acid and 1 more. Started Jun 2013; status: completed.
02
Drugs
trimetazidine
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on ChiCTR-TRC-13003298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003298.